Probiotic-derived ferrichrome induces DDIT3-mediated antitumor effects in esophageal cancer cells.

Apoptosis DDIT3 Esophageal cancer Ferrichrome Probiotics

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
30 Mar 2024
Historique:
received: 27 12 2023
revised: 07 03 2024
accepted: 11 03 2024
medline: 28 3 2024
pubmed: 28 3 2024
entrez: 28 3 2024
Statut: epublish

Résumé

Esophageal cancer, which is common among the elderly, has the poorest prognosis among gastrointestinal cancers. Previously, we demonstrated that ferrichrome, produced by the probiotic

Identifiants

DOI: 10.1016/j.heliyon.2024.e28070 PMID: 38545201 PMC: PMC10966684
pubmed: 38545201
doi: 10.1016/j.heliyon.2024.e28070
pii: S2405-8440(24)04101-X
pmc: PMC10966684
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e28070

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Mikihiro Fujiya and Hiroaki Konishi have received financial support from Kamui Pharma Inc. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Takehito Kunogi (T)

Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, 078-8510, Japan.

Hiroaki Konishi (H)

Department of Gastroenterology and Advanced Medical Sciences, Asahikawa Medical University, Asahikawa, 078-8510, Japan.

Aki Sakatani (A)

Department of Gastroenterology and Advanced Medical Sciences, Asahikawa Medical University, Asahikawa, 078-8510, Japan.

Kentaro Moriichi (K)

Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, 078-8510, Japan.

Chikage Yamamura (C)

Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, 078-8510, Japan.

Koji Yamamoto (K)

Department of Gastroenterology and Advanced Medical Sciences, Asahikawa Medical University, Asahikawa, 078-8510, Japan.

Shin Kashima (S)

Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, 078-8510, Japan.

Katsuyoshi Ando (K)

Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, 078-8510, Japan.

Nobuhiro Ueno (N)

Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, 078-8510, Japan.

Hiroki Tanaka (H)

Division of Tumor Pathology, Department of Pathology, Asahikawa Medical University, Asahikawa, 078-8510, Japan.

Toshikatsu Okumura (T)

Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, 078-8510, Japan.

Mikihiro Fujiya (M)

Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, 078-8510, Japan.
Department of Gastroenterology and Advanced Medical Sciences, Asahikawa Medical University, Asahikawa, 078-8510, Japan.

Classifications MeSH